Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 177 Posts
1 2 3 ... 12
Shifting Options Strategy To More Defensive
Article By: Financial Velociraptor Saturday, June 8, 2019 1:28 AM EDT
My options strategy continues to evolve into something that is better positioned to weather a bear market.
In this article: EL, BMY, CB, DIS, JPM, ZTS, INTC, ECL, AVGO, JNJ, UNH, NVO, BKNG
Read
E Daily Stock Pick: Bristol-Myers Squibb
Article By: Fredrik Arnold Friday, May 31, 2019 5:09 AM EDT
Bristol's price per share closed at $45.76 yesterday. A year ago its price was $52.62.
In this article: BMY
Read
Week In Review: How Trump's Policies Moved Stocks - May 12, 2019
Article By: The Fly Sunday, May 12, 2019 6:43 AM EDT
Catch up on the top industries and stocks that were impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.
In this article: AZN, BMY, GM, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, WKHS
Read
Bristol-Myers Says Celgene Deal On Track For Q3 Close After Shareholder Approval
Article By: The Fly Friday, April 12, 2019 1:40 PM EDT
More than 75% of the shares voted at the special meeting were voted in favor of the Celgene merger agreement.
In this article: BMY, CELG
Read
Wall Street's Top Stories For Friday March 29th
Article By: The Fly Friday, March 29, 2019 11:37 PM EDT
Stocks cap strong quarter with gains as White House claims progress in China talks; and more.
In this article: AZN, BMY, EXP, WFC, CELG, PRGS, RH, SGH, DWDP, BB, LYFT
Read
Undervalued Growth And Dividend Growth In Health Technology
Article By: Chuck Carnevale Wednesday, March 20, 2019 11:13 AM EDT
Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.
In this article: ABBV, AGN, AMGN, BMY, BIIB, CELG, GILD, MYL, PFE, PRGO
Read
Stocks May Have More Big Gains Ahead As Amazon Breaks Out
Article By: Michael J. Kramer Tuesday, March 19, 2019 2:00 AM EDT
Stocks finished the day higher with the S&P 500 climbing by nearly 40 basis point to 2,833.
In this article: JJCTF, IWM, SPY, AMZN, TNX, BA, BMY, CELG
Read
Biotech Stocks Hold After Brief Sell-Off Last Week…Updates
Article By: Rod Raynovich Sunday, March 10, 2019 12:22 PM EDT
Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.
In this article: BMY, MRK, RHHBY, IBB, REGN, CELG, GILD, VRTX, XBI, ABBV
Read
Small Cap Biotechs Lead The Market In 2019 Up 20% YTD
Article By: Rod Raynovich Thursday, February 28, 2019 12:20 PM EDT
Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%.
In this article: ONCE, RARE, DHR, GE, XBI, BLUE, CRSP, IWM, XLV, MRK, RHHBY, BMY, CELG, LOXO, LLY, GNMK, AMRN, TDOC
Read
Johns Hopkins, Bristol-Myers Face $1 Billion Suit
Article By: Tyler Durden Sunday, January 20, 2019 1:05 PM EDT
Johns Hopkins University, Bristol-Myers Squibb and the Rockefeller Foundation must face a $1 billion lawsuit over their roles in a top-secret program in the 1940s ran by the US government that injected hundreds of Guatemalans with syphilis.
In this article: BMY
Read
Bristol-Myers To Acquire Celgene, Puts Healthcare ETFs In Focus
Article By: Sweta Killa Thursday, January 3, 2019 11:00 PM EDT
The healthcare space is witnessing a wave of mergers and acquisitions, which could change the landscape of the healthcare business.
In this article: BMY, IBB, CELG, BBH, IHE, PJP, IEIH Also: BLUE
Read
E Bristol-Myers To Buy Celgene; A $74 Billion Deal
Article By: TalkMarkets DailyTalk Thursday, January 3, 2019 7:31 AM EDT
Bristol-Myers Squibb has struck a deal to buy Celgene in a deal valued at $74 billion in equity and cash.
In this article: BMY, CELG
Read
5 Beaten Down Stocks Of Spooky October With Upside Potential
Article By: Sweta Killa Thursday, November 1, 2018 12:30 PM EDT
Here are five stocks from the S&P 500 Index that were hit badly by market turmoil but might reverse the trend. These stocks saw positive earnings estimate revisions last month.
In this article: AMZN, NFX, BMY, ETN, CF Also: MSFT, NVDA, FB, AAPL
Read
Bristol-Myers Squibb Is Prepared To Heal Itself
Article By: Fredrik Arnold Friday, October 19, 2018 5:50 AM EDT
BMY's price per share was $56.02 at yesterday's market close. A year ago its price was $63.70 for a price loss of $7.68 per share for the year.
In this article: BMY
Read
AI And The New Health Care
Article By: John Thomas Friday, September 28, 2018 3:34 AM EDT
The first major industry to be fundamentally disrupted by AI will be health care. The next step in our intellectual evolution will be carried out by AI. By connecting our neocortex to the Internet, we will greatly improve our intelligence.
In this article: BMY, MRK, PFE, XLV, XPH
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich Saturday, July 28, 2018 9:15 PM EDT
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read
1 to 16 of 177 Posts
1 2 3 ... 12